🇺🇸 IQV — IQVIA Holdings Inc.

Salud Compra fuerte
← Volver

Precio actual

262,59 USD

Máx. histórico

282,61

1769 días

Caída desde máximo

-7,08%

Rango 52 semanas

154,50 – 284,50

Variación hoy

+1,61%

Cierre anterior

258,44

Rango de hoy

252,38 – 263,99

Volumen hoy

1.321.625

Peor caída histórica

-51,52%

30/12/2021 → 23/05/2025

Aún sin recuperar

Volatilidad anualizada ⓘ

30,05%

Información
Nombre completo
IQVIA Holdings Inc.
Divisa
USD
Mercado
NYSE
Sector
Salud
Industria
Diagnostics & Research
Empleados
95.000
PER ⓘ
31,95 (puede no estar actualizado)
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
311,89 USD (puede no estar actualizado)
Primera cotización
09/05/2013
Precio actualizado
hace 21 horas
Sobre la empresa

IQVIA Holdings Inc. provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and associated implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; strategic planning and design services; and patient and site centric solutions, as well as central laboratory, genomic, bioanalytical, ADME, discovery, vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. The company has a strategic collaboration with Kexing Biopharm Co., Ltd. for biosimilar development. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. IQVIA Holdings Inc. is based in Durham, North Carolina.

Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
18/03/2024 253,98 254,96 252,17 253,87 +0,46% 1,10% 734.300
15/03/2024 250,58 255,07 250,58 252,71 -0,61% 1,79% 1.139.800
14/03/2024 255,11 256,76 252,05 254,26 -0,54% 1,85% 989.200
13/03/2024 259,67 261,72 255,42 255,65 -1,33% 2,43% 813.000
12/03/2024 258,00 261,66 256,49 259,10 +0,20% 2,00% 839.100
11/03/2024 256,24 259,16 254,48 258,58 +0,54% 1,83% 994.000
08/03/2024 259,64 261,73 257,17 257,18 -0,55% 1,76% 842.800
07/03/2024 255,27 259,53 254,31 258,59 +2,22% 2,04% 872.400
06/03/2024 251,45 257,25 251,07 252,97 +1,11% 2,46% 843.600
05/03/2024 250,00 251,25 247,09 250,20 -0,54% 1,66% 655.800
04/03/2024 251,05 253,33 250,01 251,56 -0,35% 1,32% 642.100
01/03/2024 246,48 252,95 244,00 252,45 +2,14% 3,63% 1.144.500
29/02/2024 250,02 250,05 246,19 247,16 -1,26% 1,54% 1.393.600
28/02/2024 248,55 252,51 248,55 250,31 +0,59% 1,59% 975.000
27/02/2024 248,10 249,61 245,70 248,84 +0,55% 1,58% 629.500
26/02/2024 247,59 248,92 246,38 247,48 +0,09% 1,03% 618.400
23/02/2024 248,68 251,00 245,83 247,26 -0,03% 2,08% 973.700
22/02/2024 238,47 250,00 238,42 247,33 +4,24% 4,86% 1.936.600
21/02/2024 234,74 237,73 230,71 237,28 +1,07% 2,99% 1.186.100
20/02/2024 236,68 237,79 234,12 234,76 -1,61% 1,55% 1.015.300
16/02/2024 241,43 241,95 237,90 238,60 -1,19% 1,68% 1.021.400
15/02/2024 241,95 243,61 238,07 241,47 -0,82% 2,29% 1.677.700
14/02/2024 223,00 243,82 223,00 243,47 +13,10% 9,34% 2.798.200
13/02/2024 214,78 217,17 212,90 215,27 -1,20% 1,99% 1.353.800
12/02/2024 217,39 219,91 217,08 217,88 -0,15% 1,30% 1.034.300
09/02/2024 217,55 222,21 216,18 218,20 +0,55% 2,77% 1.143.900
08/02/2024 213,54 217,28 212,12 217,00 +1,24% 2,42% 984.200
07/02/2024 216,00 216,32 212,80 214,34 -0,50% 1,63% 965.500
06/02/2024 210,00 215,58 209,13 215,41 +2,23% 3,07% 1.239.300
05/02/2024 210,06 212,39 208,05 210,71 -0,02% 2,07% 1.162.200